These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2478770

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Details of mode and mechanism of action of denopamine, a new orally active cardiotonic agent with affinity for beta 1-receptors.
    Yokoyama H, Yanagisawa T, Taira N.
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):323-31. PubMed ID: 2464105
    [Abstract] [Full Text] [Related]

  • 3. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H, Teng KJ, Slee SJ, Kaumann AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 339(1-2):113-28. PubMed ID: 2566921
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of denopamine on the phosphorylation of cardiac muscle proteins in the perfused guinea-pig heart. Comparison with isoproterenol.
    Sasaki Y, Yabana H, Nagao T, Takeyama S.
    Biochem Pharmacol; 1988 Feb 15; 37(4):679-86. PubMed ID: 2829921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective beta 1-receptor full agonists, T-0509 and T-1583, increase the force monophasically and cyclic AMP biphasically in canine ventricular muscle.
    Kurosawa H, Satoh E, Yanagisawa T, Taira N.
    J Cardiovasc Pharmacol; 1990 Oct 15; 16(4):646-53. PubMed ID: 1706808
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
    Endoh M, Shibasaki T, Satoh H, Norota I, Ishihata A.
    J Cardiovasc Pharmacol; 1991 Mar 15; 17(3):365-75. PubMed ID: 1711596
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
    Ikeo T, Nagao T, Murata S, Yabana H, Sato M, Nakajima H.
    Arzneimittelforschung; 1986 Jul 15; 36(7):1063-8. PubMed ID: 3768073
    [Abstract] [Full Text] [Related]

  • 20. Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle.
    Endoh M, Satoh H, Norota I, Hirano K.
    Cardiovasc Drugs Ther; 1990 Aug 15; 4(4):1127-34. PubMed ID: 1964579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.